Advantage of ostarine over raloxifene and their combined treatments for muscle of estrogen-deficient rats

[1]  A. Schilling,et al.  Combination of selective androgen and estrogen receptor modulators in orchiectomized rats , 2022, Journal of Endocrinological Investigation.

[2]  M. Sassek,et al.  Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles , 2022, International journal of molecular sciences.

[3]  Jia-he Wang,et al.  The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia , 2021, Frontiers in Medicine.

[4]  M. Hafeez,et al.  Determination of Blood Calcium and Lead Concentrations in Osteoporotic and Osteopenic Patients in Pakistan , 2021, ACS omega.

[5]  S. Sehmisch,et al.  Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model , 2020, Frontiers in Endocrinology.

[6]  A. Schilling,et al.  Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis , 2020, Calcified Tissue International.

[7]  L. Lipshultz,et al.  Selective androgen receptor modulators: the future of androgen therapy? , 2020, Translational andrology and urology.

[8]  S. Francavilla,et al.  Testosterone replacement therapy , 2020, Andrology.

[9]  A. Schilling,et al.  The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats , 2019, Calcified Tissue International.

[10]  Hong-min Wu,et al.  Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells , 2019, Journal of Biomedical Science.

[11]  A. Schilling,et al.  Effect of alendronate or 8-prenylnaringenin applied as a single therapy or in combination with vibration on muscle structure and bone healing in ovariectomized rats , 2019, Bone reports.

[12]  K. Horie-Inoue,et al.  Functions of estrogen and estrogen receptor signaling on skeletal muscle , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  A. Schilling,et al.  Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis , 2019, Journal of Bone and Mineral Metabolism.

[14]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[15]  S. Sehmisch,et al.  Effect of Strontium Ranelate on the Muscle and Vertebrae of Ovariectomized Rats , 2017, Calcified Tissue International.

[16]  Sapana N. Shah,et al.  Long-Term Treatment of Tamoxifen and Raloxifene Alleviates Dystrophic Phenotype and Enhances Muscle Functions of FKRP Dystroglycanopathy. , 2018, American Journal of Pathology.

[17]  M. Komrakova,et al.  The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats , 2016, Calcified Tissue International.

[18]  J. Crawford,et al.  Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials) , 2016, Current Oncology Reports.

[19]  S. Palacios,et al.  An update on drugs for the treatment of menopausal symptoms , 2015, Expert opinion on pharmacotherapy.

[20]  C. Stuenkel.  Menopausal Hormone Therapy: Current Considerations. , 2015, Endocrinology and metabolism clinics of North America.

[21]  V. Rochira,et al.  The Endocrine Role of Estrogens on Human Male Skeleton , 2015, International journal of endocrinology.

[22]  C. Cooper,et al.  Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.

[23]  Michael Albers,et al.  Mechanism of the tissue-specific action of the selective androgen receptor modulator S-101479. , 2013, Biological & pharmaceutical bulletin.

[24]  L. Decosterd,et al.  The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy. , 2013, The American journal of pathology.

[25]  S. Khosla,et al.  Estrogen and the skeleton , 2012, Trends in Endocrinology & Metabolism.

[26]  J. Dalton,et al.  The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial , 2011, Journal of cachexia, sarcopenia and muscle.

[27]  P. C. Butera.  Estradiol and the control of food intake , 2010, Physiology & Behavior.

[28]  Xiaowei Wang,et al.  PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification , 2009, Nucleic Acids Res..

[29]  T. Herrmann,et al.  Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats , 2009, World Journal of Urology.

[30]  M. Vaisman,et al.  Raloxifene effects on thyroid gland morphology in ovariectomized rats. , 2008, Fertility and sterility.

[31]  S. Moe.  Disorders involving calcium, phosphorus, and magnesium. , 2008, Primary care.

[32]  Duane D. Miller,et al.  Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized Rats , 2007, Pharmaceutical Research.

[33]  Shalender Bhasin,et al.  Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[34]  R. Paylor,et al.  The use of behavioral test batteries, II: Effect of test interval , 2006, Physiology & Behavior.

[35]  Duane D. Miller,et al.  Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. , 2005, Endocrinology.

[36]  S. Roth,et al.  Myostatin: a therapeutic target for skeletal muscle wasting , 2004, Current opinion in clinical nutrition and metabolic care.

[37]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[38]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[39]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[40]  W. Kraemer,et al.  Fiber type composition of four hindlimb muscles of adult Fisher 344 rats , 1999, Histochemistry and Cell Biology.

[41]  C. D. Jones,et al.  Molecular determinants of tissue selectivity in estrogen receptor modulators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[43]  V. Vihko,et al.  Running-induced muscle injury and myocellular enzyme release in rats. , 1994, Journal of applied physiology.

[44]  N. Schwartz,et al.  Acute changes in pulsatile LH and FSH secretion after ovariectomy in rats: treatment with oestradiol for 24 h suppresses LH, but not FSH, for at least 48 h. , 1994, Journal of reproduction and fertility.

[45]  R. Armstrong,et al.  Muscle fiber type composition of the rat hindlimb. , 1984, The American journal of anatomy.

[46]  D. Pfaff,et al.  A histochemical study of lateral longissimus muscle in rat , 1983, Experimental Neurology.

[47]  P. Andersen,et al.  Capillary density in skeletal muscle of man. , 1975, Acta physiologica Scandinavica.

[48]  V. Edgerton,et al.  Metabolic profiles of three fiber types of skeletal muscle in guinea pigs and rabbits. , 1972, Biochemistry.

[49]  Nananda F Col,et al.  Menopause , 2009, Annals of Internal Medicine.